Past briefings

Tuesday, November 10, 2026

The top medical stories of the day, as they ran.

Morning edition

15 stories

  1. 1FDA requires GLP-1 drugs to warn of rare vision-loss riskDrugs and FDA · 11 outlets
  2. 2Lilly’s oral GLP-1 pill reduced sleep apnea in phase 3 trialsDrugs and FDA · 6 outlets
  3. 3FDA approves Bayer’s Sunharbo to reduce stroke risk in certain adultsDrugs and FDA · 4 outlets
  4. 4Police investigate after 25 Santa Barbara half-marathon runners seek carePublic health · 2 outlets
  5. 5Nebraska cancer patient says he was told he lost Medicaid coverageMedicare and Medicaid · 2 outlets
  6. 6Trump administration announces $10B in rural health awardsHealth policy · 2 outlets
  7. 7Survodutide met cardiovascular safety goal in obesity trialDrugs and FDA · 2 outlets
  8. 8MAR001 lowered triglycerides in a phase 2b trialResearch · 3 outlets
  9. 9Abiomed advises removal of certain automated Impella controllersMedical devices · 1 outlet
  10. 10Level 2, Yellow Fever in Burkina Faso, Côte d’Ivoire, and GhanaOutbreaks · 1 outlet
  11. 11AI echo drafts met accuracy standard and reduced cardiologists’ reading timeResearch · 2 outlets
  12. 12U.S. imposes new rules on ordering synthetic DNA to deter bioterrorismHealth policy · 2 outlets
  13. 13FDA approves pirtobrutinib for relapsed or refractory mantle cell lymphomaDrugs and FDA · 1 outlet
  14. 14FDA grants accelerated approval to pirtobrutinib for CLL and SLLDrugs and FDA · 1 outlet
  15. 15Study finds smartwatch ECG results vary in detecting reduced heart functionDiagnostics · 2 outlets

Evening edition

12 stories

  1. 1FDA requires GLP-1 makers to warn of rare vision-loss riskDrugs and FDA · 10 outlets
  2. 2FDA approves Bayer’s Sunharbo to reduce recurrent stroke riskDrugs and FDA · 7 outlets
  3. 3Orforglipron improved sleep apnea in two phase 3 trialsResearch · 6 outlets
  4. 4PepGen reports early Phase 2 results for myotonic dystrophy drugDrugs and FDA · 3 outlets
  5. 5Trump administration announces second $10 billion rural health award roundHealth policy · 3 outlets
  6. 6Wisconsin and New York report measles deaths involving infantsInfectious disease · 1 outlet
  7. 7Oura to acquire Counsel Health for $625 millionIndustry · 3 outlets
  8. 8Vir’s hepatitis D drug combination succeeds in first Phase 3 studyDrugs and FDA · 2 outlets
  9. 9Democrats ask drugmakers to disclose Trump pricing agreementsHealth policy · 2 outlets
  10. 10Labcorp completes $375 million acquisition of Millennium HealthIndustry · 2 outlets
  11. 11ADA publications chief resigns amid boycott of the organizationResearch · 2 outlets
  12. 12Stopping GLP-1 treatment linked to higher cardiovascular risk in diabetesResearch · 2 outlets

This Week in Medicine

This Week in Medicine

The week’s top stories, the recalls worth knowing, and a moment from medical history. Every Sunday.

Free. No spam. Unsubscribe anytime.